Fny Investment Advisers, LLC Summit Therapeutics Inc. Transaction History
Fny Investment Advisers, LLC
- $208 Million
- Q3 2024
A detailed history of Fny Investment Advisers, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 1,100 shares of SMMT stock, worth $19,657. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,100
Previous 14
7757.14%
Holding current value
$19,657
Previous $0
Infinity%
% of portfolio
0.01%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
192Shares Held
75.8MCall Options Held
2.01MPut Options Held
2.84M-
Baker Bros. Advisors LP New York, NY24.4MShares$436 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$196 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$141 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$97.2 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$62 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.6B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...